Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001415889-23-002758

Options or other derivatives

  • CHIEF SCIENTIFIC OFFICER acquired 187,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER 2023-02-15 Grant or award · Stock Option +187,000 187,000 D
Loading xslF345X03/form4-02172023_040232.xml…